SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-005869
Filing Date
2015-07-30
Accepted
2015-07-30 16:30:47
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q snss-10q_20150630.htm 10-Q 1177912
2 EX-31.1 snss-ex311_201506306.htm EX-31.1 14048
3 EX-31.2 snss-ex312_201506308.htm EX-31.2 14311
4 EX-32.1 snss-ex321_201506307.htm EX-32.1 9511
5 GRAPHIC g20150730190915717685.jpg GRAPHIC 1322
  Complete submission text file 0001564590-15-005869.txt   4642612

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snss-20150630.xml EX-101.INS 1026133
7 XBRL TAXONOMY EXTENSION SCHEMA snss-20150630.xsd EX-101.SCH 40622
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20150630_cal.xml EX-101.CAL 38552
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20150630_def.xml EX-101.DEF 102741
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20150630_lab.xml EX-101.LAB 277864
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20150630_pre.xml EX-101.PRE 199187
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 151016551
SIC: 2834 Pharmaceutical Preparations